Valeo Pharma (TSE:VPH) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Valeo Pharma Inc., a Canadian pharmaceutical firm, is delisting its Class A shares from the OTCQB Venture Market due to low trading volume and high costs, focusing instead on the TSX and FSE markets. This strategic move, aimed to consolidate trading platforms, was announced by CEO Al Moghaddam, highlighting the TSX’s senior status and advanced trading system.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.